ArticleExperimental neurobiology2026
Blockade of IRE1-XBP1 Signaling Pathway Ameliorates IL-6-dependent Nerve Damage and Neuron Pyroptosis after Subarachnoid Hemorrhage in Mice.
Article in Experimental neurobiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Subarachnoid hemorrhage (SAH) often results in severe neurological impairment. While spliced X-box binding protein 1 (XBP1s) has been implicated in brain injury, its specific role and mechanism in SAH-induced mice remain unclear. A murine SAH model was established to explore the function of XBP1 knockdown. Neurological function was evaluated through behavioral tests, brain edema measurement, and hematoxylin and eosin staining. Blood-brain barrier (BBB) integrity and neuronal pyroptosis were assessed using Evans blue extravasation, western blotting, immunofluorescence and LDH release assay. The direct interaction of IL-6 by XBP1s was confirmed using chromatin immunoprecipitation and luciferase reporter assays. Finally, the functional central to our hypothesis was verified by administering exogenous IL-6 or IL-6 blocking antibody to SAH mice. We found that XBP1s and p-IRE1 were significantly up-regulated after SAH. Knockdown of XBP1 ameliorated neurological deficits, preserved BBB integrity (as indicated by increased ZO-1/Occludin and reduced Evans blue leakage), and suppressed neuronal pyroptosis, evidenced by decreased levels of pyroptosis-related proteins and LDH release. Mechanistically, XBP1s was identified as a direct transcriptional enhancer of IL-6. In the mouse SAH model, the protective effects of XBP1 knockdown on the BBB and against pyroptosis were effectively abolished by the exogenous administration of IL-6 and were comparable to administration of the IL-6 blocking antibody. The IRE1-XBP1s signaling axis played an important role in SAH-induced neuronal damage and pyroptosis by directly up-regulating IL-6 expression. Inhibition of this axis represents a mechanistically grounded and promising strategy for SAH intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.